| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Amneal Pharmaceuticals, Inc.'s insiders have reduced their positions by a net 413,016 shares worth roughly $7.2M.
AMRX sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 61.34M | - | - | |
| CEO | 6.38M | - | - | |
| CEO | 6.38M | - | - | |
| Dir | 832.8K | - | - | |
| Dir | 344.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Kiely John | Director | Sell | 50,000 | $17.64 | $882,000.00 | -19.2% | - | - | |
| Aug 12, 2026 | Shah Nikita53 | Executive Vice President | Sell | 146,403 | $17.51 | $2,563,516.53 | -36.6% | - | - | |
| Aug 12, 2026 | Daly Jason B. | EVP, Chief Legal Officer | Sell | 216,613 | $17.41 | $3,771,050.10 | -86.0% | - | - | |
| May 11, 2026 | Autor Deborah M. | Director | Sell | 34,819 | $12.94 | $450,557.86 | -27.1% | +39.9% | - | |
| Nov 17, 2025 | Nark Ted C | Director | Sell | 50,000 | $11.72 | $586,000.00 | -14.7% | +31.2% | - | |
| Nov 12, 2025 | Shah Nikita53 | Executive Vice President | Sale+OE | 131,856 | $11.92 | $1,571,723.52 | -47.4% | +24.0% | - | |
| Aug 27, 2025 | Kiely John | Director | Sell | 32,000 | $9.23 | $295,360.00 | -12.4% | +32.9% | +92.4% | |
| Aug 25, 2025 | Shah Nikita53 | Executive Vice President | Sell | 120,832 | $9.65 | $1,166,222.72 | -45.2% | +30.9% | +93.1% | |
| Aug 20, 2025 | Boyer Andrew S | Executive Vice President | Sale+OE | 279,244 | $9.38 | $2,619,308.72 | -64.7% | +23.0% | +90.2% | |
| Aug 15, 2025 | Konidaris Tasos | Executive Vice President &CFO | Sell | 499,730 | $9.33 | $4,663,070.47 | -80.4% | +21.9% | +92.1% |